We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current 0A05 market cap is 1.74B. The company's latest EPS is EUR 2.3681 and P/E is 35.43.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 310.62M | 302.49M | 363.13M | 437.12M | 510.78M |
| Operating Income | 19.63M | 50.56M | 59.29M | 64.55M | 74.44M |
| Net Income | 11.86M | 37.09M | 51.52M | 46.25M | 47.36M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 412.56M | 441.94M | 489.27M | 584.49M | 695.87M |
| Total Liabilities | 289.33M | 277.22M | 262.87M | 309.83M | 365.83M |
| Total Equity | 123.23M | 164.72M | 226.4M | 274.66M | 330.04M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 42.64M | 59.59M | 54.06M | 73.51M | 75.13M |
| Investing | -42.04M | -34.19M | -52.04M | -65.11M | -80.61M |
| Financing | -10.98M | -6.03M | -31.21M | 3.44M | -10.13M |
| Market Cap | 1.74B |
| Price to Earnings Ratio | 35.43 |
| Price to Sales Ratio | 3.29 |
| Price to Cash Ratio | 80.71 |
| Price to Book Ratio | 5.08 |
| Dividend Yield | - |
| Shares Outstanding | 20M |
| Average Volume (1 week) | 131 |
| Average Volume (1 Month) | 419 |
| 52 Week Change | 0.00% |
| 52 Week High | 87.145 |
| 52 Week Low | 87.145 |
| Spread (Intraday) | 8.71 (9.52%) |
| Company Name | Medacta Group Sa |
| Address |
strada regina 34 mendrisio 6874 |
| Website | https://www.medacta.ch |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
